TP53 and cancer: Our group then performed blinded uterine lavage analysis using duplex sequencing (DS), an ultra-accurate ultrasensitive NGS approach (13, 14), and demonstrated detection of cancer-specific TP53 mutations in 80% of samples from high-grade serous cancer (HGSC) cases (11).